A groundbreaking implant is offering new hope to patients with refractory angina—severe chest pain that won’t respond to standard treatments. Called the coronary sinus reducer, this device narrows a vein near the heart to redirect blood flow, delivering dramatic results: 75% of patients report major pain relief. For many, it’s transformed their lives—from multiple daily attacks and constant fear to just one or two per week. The minimally invasive procedure often lets patients go home the next day, though the £11,400 cost remains a hurdle. Still experimental, it’s showing real-world safety and effectiveness, with early trials promising a potential game-changer for the 300,000 people in England living with this debilitating condition.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
